STOCK-BASED COMPENSATION (Tables)

9 Months Ended

Sep. 30, 2024

Share-Based Payment Arrangement [Abstract]

Schedule of stock option activity

The following is a summary of the Company’s stock option activity and related information for the nine months ended September 30, 2024:

	Number of Stock Options	Weighted Average Grant Date Fair Value		Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (years)
Outstanding - December 31, 2023	2,475,363	$	4.12	$	11.65	8.8
Granted	48,133	3.67		9.95		6.5
Forfeited	(227,826)	4.23		11.73
Expired	(37,045)	4.23		11.73
Outstanding - September 30, 2024	2,258,625	$	4.10	$	11.60	8.0
Exercisable - September 30, 2024	509,118

Schedule of restricted shares activity

The following is a summary of the status of the Company’s restricted shares as of September 30, 2024 and changes therein during the nine months ended:

	Number of Shares Awarded	Weighted Average Grant Date Fair Value
Outstanding - December 31, 2023	944,262	$	11.88
Granted	387,695	9.55
Forfeited	(442,347)	11.76
Vested	(115,415)	11.76
Outstanding - September 30, 2024	774,195	$	10.80

Schedule of share-based compensation expense

The following table presents the share-based compensation expense for the three and nine months ended September 30, 2024 and 2023.

	Three Months Ended September 30,				Nine Months Ended September 30,
	2024		2023		2024		2023
	(In thousands)
Stock option expense	$	373	$	403	$	1,087	$	1,199
Restricted stock expense	438		290		1,261		938
Total share-based compensation expense	$	811	$	693	$	2,348	$	2,137